February 28, 2019 8:34 AM
Centre brings 42 non-scheduled cancer drugs under price control
The Centre has brought 42 non-scheduled anti-cancer drugs under the price control, capping trade margin at 30 per cent, which will reduce their retail prices by up to 85 per cent. The National Pharmaceutical Pricing Authority (NPPA) yesterday invoked extraordinary powers in public interest, under Para 19 of the Drugs (Prices Control) Order, 2013 to bring 42 non-scheduled anti-cancer drugs under price control through trade margin rationalisation.<br />''<br />''An official release sai...